Free Newsletter
Bloomberg: Japan got Seroquel warning before U.S.
Bloomberg has been hot on the trail of the Seroquel litigation, and in its latest foray into newly unsealed documents, found that AstraZeneca in 2002 warned Japanese doctors of diabetes cases in Seroquel patients "where causality with the drug could not be ruled out." Similar U.S. warnings did not come until 2004, the news service states. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: